Received: 10 November 2021
Accepted: 30 December 2021
First Online: 1 February 2022
: We obtained the patients’ written consent for molecular genetic analyses and further scientific use, as well as for publication.
: Maike F. Dohrn has received scientific funding from Pfizer (ASPIRE 2018), has served as a paid consultant for Amicus, Akcea, Alnylam, and Pfizer, and is currently receiving a scholarship for a research fellowship by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG). Jörg B. Schulz serves at advisory boards for Biogen and Roche. Burkhard Gess received financial support from Pfizer, Grifols, and Bayer for conference contributions. Natalie Winter has received scientific funding from Pfizer (ASPIRE 2018), has served as a paid consultant for Canon and Pfizer, and is currently receiving an intramural scholarship for a research fellowship (Clinician Scientist). CH, DZ, CDO, SB, JW, KGC, US, PA, and LM have no conflicts to disclose.